FOLLOW US

Priority Healthcare Consulting

Market Access–Integrated Demand Forecasting

predictive market analysis

About Us | Our Team

We provide exceptional quantitative market research, leveraging our internal experts who have spent their entire careers in pharmaceutical market research. We uncover barriers, risks, and opportunities for your therapeutic product, predict market share with our proprietary forecasting method, and provide strategic direction on how to maximize your market share within that market. We are highly experienced market researchers who deliver high-quality results and exceed expectations on every project.

Our Team

Roger Green, Head of Strategy and Insights

Roger Green is the Founder of RG+A, a healthcare consulting firm that generated $180M in revenue over its lifetime. He built the go-to-market plans for twelve separate billion-dollar assets. With more than 30 years of experience in life sciences forecasting physician demand, Roger has pioneered innovative approaches in predictive analytics and strategic decision support that help pharmaceutical and biotechnology companies optimize product launches and market access.

Seamus Cole, Founder and Principal of PHC

Seamus Cole specializes in pharmaceutical launch forecasting that integrates both physician demand and payer dynamics. He began his career building HCP demand forecasts for global pharmaceutical companies including Pfizer, Genentech, Takeda, and others before later working at the largest payer coverage intelligence firm supporting more than 35 payer policy forecast launches. His experience across both demand forecasting and payer coverage allows him to model how prescribing behavior changes when market access barriers are introduced. 

Derek Arnold, Head of Market Access Insights and Affordability Solutions

Award-winning pharmaceutical executive with 30 years of experience leading market access , patient affordability and distribution / trade strategies. Expertise includes developing and executing winning Product / Company “Value Propositions” to Payers /PBM’s and GPO’s resulting in Customer adoption and Formulary / Medical Policy access. Proven success creating and executing complex payer contracting for branded medications across commercial, Medicare, and Medicaid markets.

Free resources

Latest Articles



We are entering one of the biggest biosimilar waves in history, both in the United States and across emerging markets, with more than 200 billion dollars in biologic drugs expected to lose exclusivity over the next few years.



Most drug launches fail at the payer level not because of price but because the story is not told clearly. Every important launch needs a thoughtful strategy to communicate a drug’s benefits to payers and give them a clear rationale for why it should be included on formulary.

CONTACT

FOLLOW US

Join our Newsletter to Receive Actionable Insights on Getting Products to Market Faster

Copyright 2024. Priority Healthcare Consulting | All rights reserved